Cogent Biosciences, Inc. (COGT)
NASDAQ: COGT · Real-Time Price · USD
37.46
+0.44 (1.19%)
At close: Mar 5, 2026, 4:00 PM EST
37.72
+0.26 (0.71%)
After-hours: Mar 5, 2026, 7:29 PM EST
Cogent Biosciences Stock Forecast
Stock Price Forecast
The 14 analysts with 12-month price forecasts for Cogent Biosciences stock have an average target of 33.5, with a low estimate of 9.00 and a high estimate of 67. The average target predicts a decrease of -10.57% from the current stock price of 37.46.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Cogent Biosciences stock from 15 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Sep '25 | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 6 | 6 | 6 | 6 | 6 | 6 |
| Buy | 3 | 3 | 3 | 3 | 4 | 5 |
| Hold | 2 | 3 | 4 | 4 | 4 | 4 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 11 | 12 | 13 | 13 | 14 | 15 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Piper Sandler | Piper Sandler | Buy Maintains $39 → $52 | Buy | Maintains | $39 → $52 | +38.81% | Feb 18, 2026 |
| Wedbush | Wedbush | Buy Reiterates $55 | Buy | Reiterates | $55 | +46.82% | Jan 21, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $50 → $52 | Strong Buy | Maintains | $50 → $52 | +38.81% | Jan 6, 2026 |
| JP Morgan | JP Morgan | Buy Maintains $65 → $67 | Buy | Maintains | $65 → $67 | +78.86% | Dec 19, 2025 |
| Needham | Needham | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Dec 8, 2025 |
Financial Forecast
Revenue This Year
29.79M
Revenue Next Year
381.45M
from 29.79M
Increased by 1,180.55%
EPS This Year
-2.16
from -2.55
EPS Next Year
-0.38
from -2.16
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 50.6M | 830.2M | |||
| Avg | 29.8M | 381.5M | |||
| Low | 9.5M | 133.6M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | - | 2,687.2% | |||
| Avg | - | 1,180.5% | |||
| Low | - | 348.4% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | -1.73 | 1.64 | |||
| Avg | -2.16 | -0.38 | |||
| Low | -2.59 | -1.55 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.